CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression
- PMID: 31337246
- DOI: 10.2217/epi-2019-0093
CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression
Abstract
Aim: To investigate the role of circRNAs in triple-negative breast cancer (TNBC) and the underlying mechanisms. Materials & methods: We performed circRNA microarrays to explore the expression profiles of TNBC cell lines. Experiments in vitro and in vivo were conducted to explore the effects of circPLK1 on tumor proliferation and metastasis as well as the interaction between circPLK1, miR-296-5p and PLK1 in TNBC. Results & conclusion: CircPLK1 was significantly upregulated in TNBC and associated with poor survivals. CircPLK1 knockdown inhibited cell growth and invasion in vitro as well as tumor occurrence and metastasis in vivo. CircPLK1-miR-296-5p-PLK1 axis regulates tumor progression by ceRNA mechanism in TNBC, indicating that circPLK1 may serve as a prognostic factor and novel therapeutic target for TNBC.
Keywords: MiR-296-5p; PLK1; ceRNAs; circPLK1; circRNAs; miRNAs; prognosis; therapy; triple-negative breast cancer; tumor occurrence and metastasis.
Similar articles
-
The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.Mol Cancer. 2020 Apr 7;19(1):73. doi: 10.1186/s12943-020-01183-9. Mol Cancer. 2020. PMID: 32264877 Free PMC article.
-
circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.Mol Cancer. 2019 Feb 11;18(1):23. doi: 10.1186/s12943-019-0946-x. Mol Cancer. 2019. PMID: 30744636 Free PMC article.
-
MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.Oncotarget. 2016 Apr 12;7(15):20381-94. doi: 10.18632/oncotarget.7953. Oncotarget. 2016. PMID: 26967387 Free PMC article.
-
Progress of non-coding RNAs in triple-negative breast cancer.Life Sci. 2021 May 1;272:119238. doi: 10.1016/j.lfs.2021.119238. Epub 2021 Feb 16. Life Sci. 2021. PMID: 33600860 Review.
-
CircRNAs in extracellular vesicles associated with triple-negative breast cancer.Cell Mol Biol (Noisy-le-grand). 2025 Jan 12;70(12):99-109. doi: 10.14715/cmb/2024.70.12.14. Cell Mol Biol (Noisy-le-grand). 2025. PMID: 39799490 Review.
Cited by
-
Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer.Noncoding RNA Res. 2024 Jan 3;9(1):262-276. doi: 10.1016/j.ncrna.2023.12.005. eCollection 2024 Mar. Noncoding RNA Res. 2024. PMID: 38282696 Free PMC article. Review.
-
Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer.Mol Ther Nucleic Acids. 2021 Jul 2;26:63-80. doi: 10.1016/j.omtn.2021.06.017. eCollection 2021 Dec 3. Mol Ther Nucleic Acids. 2021. PMID: 34513294 Free PMC article. Review.
-
CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway.Mol Cancer. 2021 Mar 1;20(1):43. doi: 10.1186/s12943-021-01332-8. Mol Cancer. 2021. PMID: 33648498 Free PMC article.
-
Role of m6A methyltransferase component VIRMA in multiple human cancers (Review).Cancer Cell Int. 2021 Mar 17;21(1):172. doi: 10.1186/s12935-021-01868-1. Cancer Cell Int. 2021. PMID: 33731118 Free PMC article. Review.
-
Ferroptosis is involved in the progression of hepatocellular carcinoma through the circ0097009/miR-1261/SLC7A11 axis.Ann Transl Med. 2021 Apr;9(8):675. doi: 10.21037/atm-21-997. Ann Transl Med. 2021. PMID: 33987373 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous